99% Apixaban CAS 503612-47-3
Ƙayyadaddun bayanai
| ITEM | STANDARD |
| Bayyanar | Fari zuwa kashe-fari mai ƙarfi |
| Tsafta | ≥ 99% |
Aikace-aikace
Apixaban wani sabon nau'i ne na maganin rigakafi na baka, sabon nau'in nau'in factor factor Xa inhibitor, wanda ake amfani da shi don hanawa da kuma kula da zubar da jini.
Apixaban sabon abu ne na baka na Xa inhibitor tare da Bristol-Myers Squibb da Pfizer suka haɓaka.Ta hanyar hana wani muhimmin coagulation factor Xa, apixaban yana hana thrombin tsararru da thrombosis.
A ranar 26 ga Afrilu, 2007, Bristol-Myers Squibb da Pfizer sun ba da sanarwar haɓaka haɗin gwiwa na sabon apixaban na maganin jijiyoyi na baki mallakar Bristol-Myers Squibb a matsayin ingantaccen madadin warfarin.
A watan Mayun 2011, apixaban shine farkon wanda aka amince da shi don rigakafin thrombosis na jini a cikin manya marasa lafiya da ke fuskantar zaɓaɓɓen hip ko gwiwa a cikin ƙasashen EU na 27, Iceland da Norway.
A ranar 20 ga Nuwamba, 2012, Hukumar Tarayyar Turai ta amince da ELIQUIS (apixaban) don rigakafin bugun jini da bugun jini a cikin manya tare da fibrillation na valvular (NVAF) tare da ɗaya ko fiye da abubuwan haɗari.
Hukumar Abinci da Magunguna ta Kanada, Japan, da Hukumar Abinci da Magunguna ta Amurka daga baya sun amince da ELIQUIS (apixaban) don rigakafin bugun jini da bugun jini a cikin manya tare da fibrillation marasa ƙarfi (NVAF) tare da abubuwan haɗari ɗaya ko fiye.
A ranar 12 ga Afrilu, 2013, an sanar da ELIQUIS (Apixaban), bisa hukuma a kasuwa a China.Apixaban wani labari ne na baka na Xa inhibitor don rigakafin thromboembolism venous (VTE) a cikin manya marasa lafiya da ke fuskantar zaɓaɓɓen hip ko gwiwa.Kaddamar da shi yana ba da sabon zaɓi mai aminci da inganci don maganin ƙwanƙwasa bayan tiyatar orthopedic a cikin aikin asibiti, kuma yana kawo labarai mai daɗi ga marasa lafiya na kasar Sin waɗanda ke fuskantar zaɓen maye gurbin hip/ gwiwa.
Nazarin asibiti sun tabbatar da cewa idan aka kwatanta da 40 MG subcutaneous allura na enoxaparin sau ɗaya a rana, 2.5 MG na ELIQUIS (Apixaban) baki sau biyu a rana ya fi tasiri a hana venous thromboembolic al'amuran bayan hip ko gwiwa maye gurbin tiyata , kuma baya kara hadarin zub da jini.
Shiryawa & Ajiya
100g/500g/1kg/25kg ko kamar yadda bukata;
Ajiye a zazzabi na ɗaki kuma a hana iska.
